Heidelberg Pharma AG (HPHA) – Company Profile and SWOT Analysis
- Pages: 57
- Published: January 2026
- Report Code: MLPH123319FSA
Heidelberg Pharma AG (HPHA) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Heidelberg Pharma AG (Heidelberg Pharma) is a biopharmaceutical company. It develops targeted cancer therapies using its proprietary antibody-drug conjugate (ADC) technology. Its lead candidate, HDP-101, uses amanitin, a potent toxin, to treat relapsed multiple myeloma by targeting BCMA. HDP-101 has shown promising results in early clinical trials and has received Orphan Drug Designation. The company is also advancing ADCs like HDP-102, targeting CD37 for B-cell lymphoma and HDP-103, targeting PSMA for metastatic prostate cancer. HDP-201, an exatecan-based ADC targeting GCC, is being developed for gastrointestinal cancers. The company also has a legacy portfolio, including TLX250-CDx for renal cancer diagnostics and a therapeutic version of girentuximab. Heidelberg Pharma is headquartered in Ladenburg, Germany.
Scope
• Detailed information on Heidelberg Pharma AG required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Heidelberg Pharma AG in the form of a SWOT analysis
• An in-depth view of the business model of Heidelberg Pharma AG including a breakdown and examination of key business segments
• News about Heidelberg Pharma AG, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Heidelberg Pharma AG and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Heidelberg Pharma AG as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Heidelberg Pharma AGs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
MediGene AG
4SC AG
Navigo Proteins GmbH
Biotest AG
Baxter Oncology GmbH
Merck KGaA
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.